---
schema_version: "secwatch.filing_event.v1"
accession: "0001646972-26-000028"
form_type: "8-K"
ticker: "ACI"
cik: "0001646972"
company_name: "Albertsons Companies, Inc."
filed_at: "2026-04-14T23:59:59+00:00"
generated_at: "2026-05-15T06:23:53.351422+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Albertsons Q4 adj EPS $0.48 (+4% YoY); opioid charge $774M; dividend +13%; buyback to $2B

## Summary
- Q4 adj net income $252M ($0.48) vs $269.5M ($0.46) prior year; adj EBITDA $903M.
- Recorded $774M ($600M after-tax) opioid settlement charge; framework to pay $774M over 9 years.
- FY2026 guidance: adj EPS $2.22-$2.32, adj EBITDA $3.85-$3.925B, identical sales 0.0-1.0%.
- Quarterly dividend raised 13% to $0.17 (annualized $0.68); payable May 8 to April 24 record.
- Share repurchase authorization increased by $900M to $2.0B remaining; completed $1.5B buyback in FY2025.

## SEC filing metadata
- accession: 0001646972-26-000028
- form_type: 8-K
- ticker: ACI
- cik: 0001646972
- company_name: Albertsons Companies, Inc.
- filed_at: 2026-04-14T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1646972/000164697226000028/0001646972-26-000028-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1646972/000164697226000028/aci-20260414.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001646972-26-000028
- JSON: https://secwatch.observer/filing/0001646972-26-000028.json
- Plain text: https://secwatch.observer/filing/0001646972-26-000028.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.